Medibank Historical Cash Flow

MPL Stock

3.82 0.03 0.79%

Analysis of Medibank Private cash flow over time is an excellent tool to project Medibank Private future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 398.7 M or Depreciation of 108 M as it is a great indicator of Medibank Private ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Medibank Private latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Medibank Private is a good buy for the upcoming year.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medibank Private. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Medibank Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Medibank balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Medibank's non-liquid assets can be easily converted into cash.

Medibank Private Cash Flow Chart

At this time, Medibank Private's Total Cashflows From Investing Activities is comparatively stable compared to the past year. Other Cashflows From Investing Activities is likely to gain to about 77.9 M in 2025, whereas Dividends Paid is likely to drop slightly above 370.3 M in 2025.

Change To Inventory Change In Working Capital Other Cashflows From Financing Activities Depreciation

Change To Inventory

The increase or decrease in the amount of inventory a company has over a certain period.

Change In Working Capital

The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.

Depreciation

Depreciation indicates how much of Medibank Private value has been used up. For tax purposes Medibank Private can deduct the cost of the tangible assets it purchases as business expenses. However, Medibank Private must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.

Most accounts from Medibank Private's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Medibank Private current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medibank Private. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Capital Expenditures	41.9M	57.6M	66.2M	69.6M
Dividends Paid	374.5M	426.9M	490.9M	370.3M

Capital Expenditures Dividends Paid

Medibank Private cash flow statement Correlations

	Change To Inventory	Change In Cash	Free Cash Flow	Change In Working Capital	Depreciation	Other Non Cash Items	Dividends Paid	Capital Expenditures	Change To Account Receivables	Net Income	End Period Cash Flow	Investments	Begin Period Cash Flow	Change To Operating Activities	Change To Netincome	Change To Liabilities	Stock Based Compensation	Sale Purchase Of Stock	Net Borrowings
Change To Inventory		-0.06	-0.27	-0.77	-0.78	-0.57	-0.29	-0.57	0.0	0.59	0.23	0.03	0.35	0.46	0.47	-0.14	-0.16	0.63	0.26
Change In Cash	-0.06		-0.36	0.31	-0.03	-0.25	-0.59	0.03	0.64	-0.34	0.77	0.4	0.29	-0.01	0.32	0.26	-0.45	0.08	0.28
Free Cash Flow	-0.27	-0.36		0.43	0.63	0.86	0.7	0.32	-0.28	-0.29	-0.24	-0.46	-0.58	0.07	-0.21	-0.34	0.33	-0.47	-0.48
Change In Working Capital	-0.77	0.31	0.43		0.88	0.61	0.26	0.62	0.26	-0.85	0.02	-0.02	-0.39	-0.59	-0.47	0.3	-0.03	-0.83	-0.36
Depreciation	-0.78	-0.03	0.63	0.88		0.77	0.59	0.75	-0.12	-0.72	-0.13	-0.12	-0.46	-0.43	-0.49	0.05	0.22	-0.89	-0.61
Other Non Cash Items	-0.57	-0.25	0.86	0.61	0.77		0.67	0.59	-0.25	-0.6	-0.15	-0.42	-0.42	0.01	-0.14	-0.15	0.14	-0.54	-0.43
Dividends Paid	-0.29	-0.59	0.7	0.26	0.59	0.67		0.53	-0.67	-0.22	-0.33	0.0	-0.55	-0.14	-0.33	-0.37	0.38	-0.51	-0.43
Capital Expenditures	-0.57	0.03	0.32	0.62	0.75	0.59	0.53		-0.31	-0.75	0.15	-0.02	0.02	-0.27	-0.14	0.32	0.11	-0.64	-0.54
Change To Account Receivables	0.0	0.64	-0.28	0.26	-0.12	-0.25	-0.67	-0.31		-0.23	0.38	-0.03	0.29	-0.05	0.18	0.3	-0.53	0.08	0.42
Net Income	0.59	-0.34	-0.29	-0.85	-0.72	-0.6	-0.22	-0.75	-0.23		-0.26	0.02	0.05	0.39	0.13	-0.43	0.37	0.6	0.15
End Period Cash Flow	0.23	0.77	-0.24	0.02	-0.13	-0.15	-0.33	0.15	0.38	-0.26		0.35	0.57	0.4	0.61	0.03	-0.51	0.2	0.3
Investments	0.03	0.4	-0.46	-0.02	-0.12	-0.42	0.0	-0.02	-0.03	0.02	0.35		-0.13	-0.3	-0.08	-0.15	-0.19	0.05	0.36
Begin Period Cash Flow	0.35	0.29	-0.58	-0.39	-0.46	-0.42	-0.55	0.02	0.29	0.05	0.57	-0.13		0.46	0.64	0.36	-0.37	0.44	0.26
Change To Operating Activities	0.46	-0.01	0.07	-0.59	-0.43	0.01	-0.14	-0.27	-0.05	0.39	0.4	-0.3	0.46		0.82	-0.51	-0.11	0.63	0.19
Change To Netincome	0.47	0.32	-0.21	-0.47	-0.49	-0.14	-0.33	-0.14	0.18	0.13	0.61	-0.08	0.64	0.82		-0.17	-0.33	0.7	0.34
Change To Liabilities	-0.14	0.26	-0.34	0.3	0.05	-0.15	-0.37	0.32	0.3	-0.43	0.03	-0.15	0.36	-0.51	-0.17		-0.19	-0.16	-0.1
Stock Based Compensation	-0.16	-0.45	0.33	-0.03	0.22	0.14	0.38	0.11	-0.53	0.37	-0.51	-0.19	-0.37	-0.11	-0.33	-0.19		-0.26	-0.67
Sale Purchase Of Stock	0.63	0.08	-0.47	-0.83	-0.89	-0.54	-0.51	-0.64	0.08	0.6	0.2	0.05	0.44	0.63	0.7	-0.16	-0.26		0.62
Net Borrowings	0.26	0.28	-0.48	-0.36	-0.61	-0.43	-0.43	-0.54	0.42	0.15	0.3	0.36	0.26	0.19	0.34	-0.1	-0.67	0.62

Click cells to compare fundamentals

Medibank Private Account Relationship Matchups

Medibank Private cash flow statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Change In Cash	(199.7M)	(75M)	(176.1M)	270.4M	243.4M	255.5M
Free Cash Flow	447.1M	913.4M	142.6M	810.9M	932.5M	467.2M
Change In Working Capital	(8.8M)	(11.1M)	(22M)	330.2M	379.7M	398.7M
Other Cashflows From Financing Activities	(37M)	(38.8M)	(39.7M)	(51.6M)	(59.3M)	(62.3M)
Depreciation	45.1M	41.2M	40.7M	89.4M	102.8M	108.0M
Other Non Cash Items	(4.1M)	513.4M	(367.3M)	445M	511.8M	537.3M
Dividends Paid	333.2M	358M	374.5M	426.9M	490.9M	370.3M
Total Cash From Operating Activities	482.2M	948.5M	184.5M	868.5M	998.8M	1.0B
Change To Account Receivables	9.9M	(8.8M)	(11.1M)	(22M)	8.9M	9.4M
Net Income	441.2M	393.9M	511.1M	3.9M	4.5M	4.3M
Total Cash From Financing Activities	(375.8M)	(399.9M)	(419.1M)	(487.3M)	(438.6M)	(460.5M)
End Period Cash Flow	671.7M	596.7M	420.6M	691M	621.9M	494.9M
Investments	(284.1M)	(602.7M)	58.5M	(110.8M)	(99.7M)	(104.7M)
Begin Period Cash Flow	871.4M	671.7M	596.7M	420.6M	378.5M	489.6M
Total Cashflows From Investing Activities	109.2M	(306.1M)	(623.6M)	58.5M	52.7M	55.3M
Change To Operating Activities	228.1M	71.4M	282.8M	(180.5M)	(207.6M)	(197.2M)
Other Cashflows From Investing Activities	13.1M	14.2M	100.4M	64.5M	74.2M	77.9M
Change To Netincome	13.8M	(111M)	30.2M	(126.9M)	(145.9M)	(153.2M)
Change To Liabilities	(157.6M)	31.3M	14.5M	99.2M	89.3M	93.7M
Stock Based Compensation	5.2M	5.9M	6.7M	3.3M	3.8M	4.4M
Sale Purchase Of Stock	(5.6M)	(3.1M)	(4.9M)	(7.5M)	(6.8M)	(7.1M)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Medibank Stock Analysis

When running Medibank Private's price analysis, check to measure Medibank Private's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medibank Private is operating at the current time. Most of Medibank Private's value examination focuses on studying past and present price action to predict the probability of Medibank Private's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medibank Private's price. Additionally, you may evaluate how the addition of Medibank Private to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC